Abiopharma

🔍 Carson Seana (Executive)

Company: Bausch Health Companies Inc. (BHC)

Report Date: 2025-09-05

Detailed Transactions and Holdings:

• Sold 51,337 shares of Common Shares, No Par Value at $7.35 per share (Direct)
  Date: 2025-09-05 | Code: F | equity_swap_involved: 0 | shares_owned_after: 512,955.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 13,370 shares of Common Shares, No Par Value at $7.31 per share (Direct)
  Date: 2025-09-08 | Code: S | equity_swap_involved: 0 | shares_owned_after: 499,585.00 | transaction_form_type: 4 | Footnotes: F2

Footnotes:

• F1: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units.
• F2: Represents shares of common stock sold in the open market pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on May 7, 2025.